BVNKF
Price:
$28.13
Market Cap:
$15.83B
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II ...[Read more]
Industry
Biotechnology
IPO Date
2010-10-15
Stock Exchange
PNK
Ticker
BVNKF
According to Bavarian Nordic A/S’s latest financial reports and current stock price. The company's current Current Ratio is 1.69. This represents a change of 0.00% compared to the average of 1.69 of the last 4 quarters.
The mean historical Current Ratio of Bavarian Nordic A/S over the last ten years is 3.33. The current 1.69 Current Ratio has changed 4.96% with respect to the historical average. Over the past ten years (40 quarters), BVNKF's Current Ratio was at its highest in in the December 2017 quarter at 11.23. The Current Ratio was at its lowest in in the December 2019 quarter at 0.32.
Average
3.33
Median
2.43
Minimum
0.32
Maximum
11.23
Discovering the peaks and valleys of Bavarian Nordic A/S Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 681.62%
Maximum Annual Current Ratio = 11.23
Minimum Annual Increase = -93.84%
Minimum Annual Current Ratio = 0.32
Year | Current Ratio | Change |
---|---|---|
2023 | 1.94 | -1.15% |
2022 | 1.96 | -21.28% |
2021 | 2.49 | -0.38% |
2020 | 2.50 | 681.62% |
2019 | 0.32 | -93.84% |
2018 | 5.20 | -53.74% |
2017 | 11.23 | 270.01% |
2016 | 3.04 | 27.61% |
2015 | 2.38 | 5.20% |
2014 | 2.26 | -2.23% |
The current Current Ratio of Bavarian Nordic A/S (BVNKF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.13
5-year avg
1.84
10-year avg
3.33
Bavarian Nordic A/S’s Current Ratio is less than AN2 Therapeutics, Inc. (9.75), less than Miromatrix Medical Inc. (3.46), greater than Inhibikase Therapeutics, Inc. (0.85), less than PMV Pharmaceuticals, Inc. (13.98), less than Anebulo Pharmaceuticals, Inc. (3.45), less than Molecular Partners AG (14.33), less than Mineralys Therapeutics, Inc. (8.55), less than Pharvaris N.V. (19.08), less than PepGen Inc. (8.47), less than Edgewise Therapeutics, Inc. (26.35), less than Rallybio Corporation (9.55), less than Opthea Limited (2.94), less than Replimune Group, Inc. (10.11), less than Nuvalent, Inc. (23.07), less than Ventyx Biosciences, Inc. (23.52), greater than Ascendis Pharma A/S (1.16), less than United Therapeutics Corporation (4.58), less than Aura Biosciences, Inc. (12.47), greater than Axcella Health Inc. (1.21), greater than H-CYTE, Inc. (0.01), less than Antibe Therapeutics Inc. (10.06),
Company | Current Ratio | Market cap |
---|---|---|
9.75 | $39.99M | |
3.46 | $92.95M | |
0.85 | $155.21M | |
13.98 | $83.31M | |
3.45 | $37.86M | |
14.33 | $219.11M | |
8.55 | $621.09M | |
19.08 | $1.20B | |
8.47 | $143.75M | |
26.35 | $3.05B | |
9.55 | $42.32M | |
2.94 | $486.27M | |
10.11 | $1.02B | |
23.07 | $6.75B | |
23.52 | $130.81M | |
1.16 | $7.76B | |
4.58 | $16.65B | |
12.47 | $443.97M | |
1.21 | $0 | |
0.01 | $624.98K | |
10.06 | $11.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bavarian Nordic A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bavarian Nordic A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Bavarian Nordic A/S's Current Ratio?
How is the Current Ratio calculated for Bavarian Nordic A/S (BVNKF)?
What is the highest Current Ratio for Bavarian Nordic A/S (BVNKF)?
What is the 3-year average Current Ratio for Bavarian Nordic A/S (BVNKF)?
What is the 5-year average Current Ratio for Bavarian Nordic A/S (BVNKF)?
How does the current Current Ratio for Bavarian Nordic A/S (BVNKF) compare to its historical average?